Research ArticleCardiovascular
Histamine H4-Receptors Inhibit Mast Cell Renin Release in Ischemia/Reperfusion via Protein Kinase Cε-Dependent Aldehyde Dehydrogenase Type-2 Activation
Silvia Aldi, Ken-ichi Takano, Kengo Tomita, Kenichiro Koda, Noel Y.-K. Chan, Alice Marino, Mariselis Salazar-Rodriguez, Robin L. Thurmond and Roberto Levi
Journal of Pharmacology and Experimental Therapeutics June 2014, 349 (3) 508-517; DOI: https://doi.org/10.1124/jpet.114.214122
Silvia Aldi
Department of Pharmacology, Weill Cornell Medical College, New York, New York, (S.A., K.-i.T., K.T., K.K., N.C., A.M., M.S.-R., R.L.); and Department of Immunology, Janssen Research & Development, L.L.C., San Diego, California (R.L.T.)
Ken-ichi Takano
Department of Pharmacology, Weill Cornell Medical College, New York, New York, (S.A., K.-i.T., K.T., K.K., N.C., A.M., M.S.-R., R.L.); and Department of Immunology, Janssen Research & Development, L.L.C., San Diego, California (R.L.T.)
Kengo Tomita
Department of Pharmacology, Weill Cornell Medical College, New York, New York, (S.A., K.-i.T., K.T., K.K., N.C., A.M., M.S.-R., R.L.); and Department of Immunology, Janssen Research & Development, L.L.C., San Diego, California (R.L.T.)
Kenichiro Koda
Department of Pharmacology, Weill Cornell Medical College, New York, New York, (S.A., K.-i.T., K.T., K.K., N.C., A.M., M.S.-R., R.L.); and Department of Immunology, Janssen Research & Development, L.L.C., San Diego, California (R.L.T.)
Noel Y.-K. Chan
Department of Pharmacology, Weill Cornell Medical College, New York, New York, (S.A., K.-i.T., K.T., K.K., N.C., A.M., M.S.-R., R.L.); and Department of Immunology, Janssen Research & Development, L.L.C., San Diego, California (R.L.T.)
Alice Marino
Department of Pharmacology, Weill Cornell Medical College, New York, New York, (S.A., K.-i.T., K.T., K.K., N.C., A.M., M.S.-R., R.L.); and Department of Immunology, Janssen Research & Development, L.L.C., San Diego, California (R.L.T.)
Mariselis Salazar-Rodriguez
Department of Pharmacology, Weill Cornell Medical College, New York, New York, (S.A., K.-i.T., K.T., K.K., N.C., A.M., M.S.-R., R.L.); and Department of Immunology, Janssen Research & Development, L.L.C., San Diego, California (R.L.T.)
Robin L. Thurmond
Department of Pharmacology, Weill Cornell Medical College, New York, New York, (S.A., K.-i.T., K.T., K.K., N.C., A.M., M.S.-R., R.L.); and Department of Immunology, Janssen Research & Development, L.L.C., San Diego, California (R.L.T.)
Roberto Levi
Department of Pharmacology, Weill Cornell Medical College, New York, New York, (S.A., K.-i.T., K.T., K.K., N.C., A.M., M.S.-R., R.L.); and Department of Immunology, Janssen Research & Development, L.L.C., San Diego, California (R.L.T.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
H4R Inhibit Mast Cell Renin Release
Silvia Aldi, Ken-ichi Takano, Kengo Tomita, Kenichiro Koda, Noel Y.-K. Chan, Alice Marino, Mariselis Salazar-Rodriguez, Robin L. Thurmond and Roberto Levi
Journal of Pharmacology and Experimental Therapeutics June 1, 2014, 349 (3) 508-517; DOI: https://doi.org/10.1124/jpet.114.214122
Research ArticleCardiovascular
H4R Inhibit Mast Cell Renin Release
Silvia Aldi, Ken-ichi Takano, Kengo Tomita, Kenichiro Koda, Noel Y.-K. Chan, Alice Marino, Mariselis Salazar-Rodriguez, Robin L. Thurmond and Roberto Levi
Journal of Pharmacology and Experimental Therapeutics June 1, 2014, 349 (3) 508-517; DOI: https://doi.org/10.1124/jpet.114.214122
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement